Key takeaways:
- Overflow incontinence from incomplete bladder emptying is an underrecognized presentation in women and may warrant thyroid evaluation, particularly when accompanied by systemic symptoms such as cold intolerance, fatigue, hair loss, or new-onset constipation.
- Life transitions including the postpartum period and perimenopause are associated with thyroid changes and overlapping symptom profiles that can obscure diagnosis.
- Management should combine thyroid treatment with behavioral strategies—timed voiding, fluid management, pelvic floor therapy, and urge suppression—with realistic expectations that improvement may take 8 to 12 weeks.
Urinary incontinence in women is frequently attributed to stress or urge etiologies, but clinicians should consider an underlying thyroid imbalance—particularly hypothyroidism—when patients present with new or worsening symptoms, according to Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES, founder of the Fosnight Center for Sexual Health and a medical advisor for Aeroflow Urology.
Fosnight noted that incomplete bladder emptying is an underrecognized contributor to urinary incontinence in women and one that may signal a thyroid-related etiology.
"We automatically attribute to women who are having urinary incontinence that it must be stress incontinence or urge," she said. "We forget that women can also have incomplete bladder emptying and that it's an overflow that can lead to that."
She recommended screening for overflow symptoms—hesitancy, dribbling, weak urinary stream, and incomplete emptying—and measuring post-void residual as a straightforward clinical step.
"Most GYN offices are going to have an ultrasound machine," she said, adding that a post-void residual can be obtained using a standard suprapubic ultrasound. Retrospective data, she noted, suggest that a significant proportion of women with hypothyroidism also report stress, urge, or mixed incontinence, pointing to a potential mechanistic link.
New-onset incontinence should prompt a broader symptom review oriented toward hypothyroidism. Fosnight outlined several clinical red flags: cold intolerance, new-onset constipation, fatigue, unrefreshing sleep, and changes in skin, hair, or nails—particularly hair loss. A personal or family history of thyroid disease or autoimmune conditions should also be elicited.
"Women have more autoimmune conditions, so don't forget to ask about those," she said.
Life transitions are another trigger for thyroid dysfunction worth considering. "We know postpartum you can definitely see some changes in thyroid, and as we transition in perimenopause and menopause, some of those symptoms are overlapping," Fosnight said, adding that the Menopause Society encourages practitioners to screen for thyroid concerns before initiating hormone therapy.
For women managing incontinence alongside thyroid treatment, Fosnight advocated a structured, data-driven approach. She recommended bladder diaries, timed voiding every 2 to 3 hours, urge suppression techniques including brief pelvic floor contractions or diaphragmatic breathing, and front-loading fluid intake earlier in the day to reduce nocturia. Pelvic floor physical therapy was highlighted as a valuable adjunct, though she cautioned that results require time.
"It could take 8 to 12 weeks for people to see some improvement," she said.
Setting realistic expectations is essential, particularly when thyroid medication is part of the treatment plan.
"Once things are more balanced, you have more harmony in those endocrine functions—your bladder and your pelvis will follow suit," Fosnight said. She emphasized shared decision-making as central to patient engagement.
"When patients feel that they are a part of the conversation and not the center of the conversation, they are more apt to be a part of the care and the action plan."
